QUALITYCRO

BENCHMARKING

PHASE II/III

CRO Quality Benchmarking –

Phase II/III Service Providers (2014)

Info@ISRreports.com

©2014 Industry Standard Research www.ISRreports.com

PREVIEW

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 2

act with confidence

Report Overview

In its 6th year, ISR’s “CRO Quality Benchmarking – Phase II/III Service Providers (2014)” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied satisfaction ratings from 474 service encounters across 29 Phase II/III CROs, making this report the most comprehensive assessment of CRO service quality in the industry.

273Charts and Graphs

148Respondents

152Pages

474Service Encounters 1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions

• Phase II/III Leaders• Proposal Volume• Service Provider Usage• Service Provider Preference• Service Provider Cost Perceptions

2. Service Provider Selection Drivers• Most Important Service Provider Attributes• Service Provider Attributes Gaining Importance

3. Service Provider Performance and Scorecards Across Attributes• “Staff Characteristics” Ratings• “Operational Excellence” Ratings• “Organizational & Finance” Ratings

4. Service Provider Service Quality Profiles

How you can use this report:Study Sponsors• Make a more informed purchase of Phase II/

III services by understanding which service providers best fit your company’s needs

• Broaden your Phase II/III CRO evaluation list by accessing peer-based service quality ratings across 25 critical attributes

• Pinpoint potential delivery concerns early in a sponsor-CRO relationship/ evaluation in order to develop proactive strategies to address potential gaps

Clinical Service Providers• Uncover your own — and competitor —

delivery strengths and weaknesses• Design messaging to tout your company’s

strengths• Compete more effectively by understanding

buyers’ selection criteria and outsourcing trends

NEXT: Companies Included

Report Structure:

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 3

act with confidence

Service Quality MetricsStaff Characteristics• Commercial market knowledge• CRA quality• Staff turnover• Project manager quality• Project team chemistry• Responsiveness• Therapeutic expertise • Timely project communications

Organization & Finance Characteristics• Breadth of services• Financial strength / stability• Global footprint• Low cost• Minimizing change orders

Operational Excellence• Data quality• Local Market / Regulatory Knowledge• Meeting database lock timelines• Meeting first patient / first visit

timelines• Meeting overall project timelines• Network of sites/ investigators • Offered innovative solutions• Patient recruitment strategy• Speed of site/ investigator

recruitment• Speed of site start-up• Technology for real-time access to

data• Up-front contingency planning and

trial risk management

CROs Included in this Report• Accenture• Aptiv Solutions• BioClinica• Charles River Laboratories• Chiltern• Clinical Research Services

(CRS)• Clinipace• Clinsys• Cognizant

• Covance• DCRI – Duke• Encorium• Eurofins• Frontage• HungaroTrial• ICON• INC Research• inVentiv Health Clinical• Medpace

• PAREXEL• PPD• PRA• Premier Research• Quintiles• Rho• SGS Life Sciences• Tata• Theorem• Worldwide Clinical Trials

9% C-level

12% President/ VP

52% Director

24% Manager

3% Other

Participant Job Title Participant Geography Participant Company Size

55% North

America

34% Europe

Asia/ Other

11%

55% Large Companies (R&D $1B or more)

23% Mid-Size Companies (R&D $100M-$999M)

22% Small Companies (R&D less than $100M)

Report Metrics

Respondent Demographics (N=148)

Participant Experience: Mean = 16 years

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 4

act with confidence

Table of Contents

For full table of contents and additional sample pages, download the full preview from our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iiiii-service-providers-2014/

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 5

act with confidence

act with confidence

Introduction

www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase II/III Service Providers (2014) 7

IntroductionWelcome to ISR’s 2014 CRO Quality Benchmarking Phase II/III report� This report marks the sixth edition of this study and, though the study design is revisited and refreshed each year to account for evolution within the industry, the impetus for per-forming this research remains the same� Over time, Industry Standard Research has accumulated a wealth of knowledge around service quality and CRO performance� Understanding and utilizing this information allows stakeholders within the industry to make informed decisions when choosing a CRO for Phase II/III services�

ISR knows that selecting a CRO isn’t easy� There is a myriad of factors to evaluate for each CRO being considered� Does the provider have the necessary therapeutic ex-pertise? Will the trial be completed on time and within budget? Will the provider be able to successfully recruit patients? Are the project managers of high caliber? With-out prior experience with a provider, purchasers of CRO services are often forced to rely on incomplete or biased assessments of CRO performance passed on through word of mouth from peers within the industry�

In the CRO Quality Benchmarking Phase II/III report, ISR provides the data necessary to answer these questions – and many more – with confidence� 148 decision-makers have weighed in with their CRO selection criteria and outsourcing behaviors� They have provided feedback on 474 recent service encounters across 29 Phase II/III CROs� 16 providers have received detailed profiles, eight large CROs and eight mid-size/specialty CROs� Find out in which areas large CROs dominate and in which performance areas the smaller CROs shine�

Not only does this report enable more educated purchases of CRO services, it also allows providers to get a behind-the-scenes look at customers’ perceptions of their performance� Providers can determine areas of strength and understand where they may need to close the gap relative to competitors� As they say, knowledge is power� Having a grasp on customer perceptions of strengths and weaknesses will help CROs effectively promote their strengths and improve areas in which they are falling short�

Sample Page

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 6

act with confidence

Sample Page

act with confidence

Service Provider Performance and Scorecards Across Attributes

www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase II/III Service Providers (2014) 26

For sponsors and service providers – use these Consumer Reports-style summary charts to quickly ascertain the strengths and weaknesses of the service providers profiled in this report.

Company A

Company B

Company C

Company D

Company E

Company F

Company G

Company H

Company I

Company J

Company K

Company L

Company M

Company N

Company O

Company P

Respon-sivenessCRA Quality

Project manager quality

Sta� turnover

Project team chemistry

Therapeutic expertise

Commercial Market

Knowledge

Sta� Characteristics

©2014 Industry Standard Research

Ratings Key: Clear leadership Better than most About average Falling a bit short

Timely project communications

©2014 Industry Standard Research

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 7

act with confidence

Sample PageFor full table of contents and additional sample pages, download the full preview from our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iiiii-service-providers-2014/

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 8

act with confidence

Ordering Information

Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services indus-tries.  With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.   For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.

About Industry Standard Research

For pricing and ordering information, please visit our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iiiii-service-providers-2014/

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 9

act with confidence

www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 9

act with confidence

www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10

act with confidence

www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10

act with confidence

The ISR DifferenceCustom-quality syndicated market research

www.ISRreports.com

ISR's Reports The Common Syndicated Reportvs.

How confident are you?

vs.Data Collection

ISR's proprietary data collection tools and channels support fast,

high quality data collection

Struggle to recruit the right targets and enough of them

vs.Sample Sizes

Robust sample sizes that instill confidence

Often insufficient industry representation that leaves you

defending results

vs.vs.Research methods

Mostly primary research;

always appropriate for the topic

One size fits all; usually publically

available data

vs.vs.Respondents

Sophisticated screening ensures genuine decision-makers

Undisclosed methodologies and

respondent demographics

vs.vs.Analysts

Decades of experience means more insights that are

immediately usable

Junior analysts capable of reporting numbers